The Prescription: 17th August Issue
PSM INDIA CapsulesEditor’s Emulsion Dose of the Day National Injections Drug Laws & Policy Injections Pharma Injections Global Injections DRUG DOPES UpComing Events PSM Pill FAQ Laughter Dose Blog Addict Contact Us
News Archive
EDITOR'S EMULSION

Pooja Khaitan

My family joins me in wishing all our Indian readers a very Happy Independence Day! Let's pledge to move towards a Healthy & Safe Nation!
The public initiative on "Improving access to quality healthcare for all” under the National Health Assurance Mission"at Varanasi, 9th-11th Aug 2015 has been a great success. We thank all our honourable dignitaries, speakers, healthcare stakeholders and above all the presence of the enthusiastic participants who made this event a grand success! With your further cooperation we wish to conduct and carry on with our enduring mission of universal access to safe, affordable, quality medicine and healthcare to every Indian, especially the poor and elderly.
Read More>>>

If you have any suggestions, comments or queries, please email me at pooja@safemedicinesindia.in.
You may find our previous issues on www.safemedicinesindia.in or in the NEWS ARCHIVE section of every issue of The PRESCRIPTION, in case you’ve missed any of them. You may also look us up on Facebook under Partnership for Safe Medicines India

"Call PSM India toll free helpline 1800 - 11- 4424, to bring cases of spurious medicines or any kind of adverse drug reaction to the notice of the authorities.
Please visit our website www.safemedicinesindia.in if you wish to learn about us .
To register a complaint kindly visit our consumer redressal website www.consumerconexion.org

Happy Reading !
Stay Safe. Stay Healthy !

Pooja Khaitan
Chief Editor , The PRESCRIPTION Partnership for Safe Medicines India.

DOSE OF THE DAY

“With the government keen to drive growth, the pharma industry should put in place a mechanism to address these issues with the government on similar lines of the western world. Like for instance, the State and National Pharma Industry associations should be engaged in a constant dialogue with the government to ease any sort of pharma challenges ---- adopt a zero tolerance-zero defect attitude and prepare itself to tread such a path”.

Shri. Sudhansh Pant,
Joint Secretary,
Department of Pharmaceuticals (DoP)

An Exclusive Benefit for PSM India Readers SUBSCRIBE FB Tw
PSM India Capsules
Project on Universal Healthcare coverage for the poor and elderly launched successfully in Varanasi

In order to make the Healthcare Delivery System accountable and accessible to the poor and the elderly citizens in India a Pilot Initiative in Varanasi was launched and a National Consultation with Experts from India & Overseas was organised from 09-11 August 2015 in collaboration with Government of India, Mata Anandamayee Hospital, Consumer Online Foundation and Partnership for Safe Medicines India Initiative www.safemedicinesindia.in The event was attended by 150+ delegates in Varanasi

Read More
National Injections
Freebies for docs: Government ban set to replace voluntary code Mumbai : The government is planning to make the code of conduct which bans unethical marketing practices doling out freebies and sponsoring jaunts of doctors mandatory on the drug and medical devices industry, making it tighter and providing teeth to it. The code banning cruise tickets, freebies and exotic paid-vacations for doctors, sponsored by drug companies, is voluntary at present, but with concerns being expressed that it lacks "teeth", and with rampant violations, the government seems to be veering around to make it binding by making it a regulation Read More
9092 drug samples found to be substandard in last 3 years New Delhi, 31 July 2015: The Centre declared that out of the 2,05,448 drug samples tested from 36 states and union territories in the last three years, 9,092 samples were declared 'not of standard quality' while 271 were found to be spurious or adulterated.Read More
Negligence costs boy his leg, 4 docs barred for a mythNew Delhi, 1 Aug 2015: Delhi Medical Council on Friday barred four doctors-two each from Hindu Rao and Safdarjung hospitals-from practising for the next one month. They were found guilty of medical negligence that led to the amputation of a 10-year-old boy's leg. Read More
75% of Indian population unaware of hepatitisNew Delhi: With over 75% of people in India being unaware about the existence of Hepatitis, the leading gastroenterologists of the country have decided to start an online data registry detailing the rising number of hepatitis patients. Read More
Govt, private hospitals fail to handle biomedical waste despite its sharp rise over yearsHyderabad, 7th Aug 2015: With growing number of hospitals and healthcare facilities in the country, the load of biomedical waste in the country is increasing every year. Despite various amendments in the law governing the regulations of biomedical waste management and initiatives taken up by the Central and State Pollution Control Boards, majority of hospitals and healthcare facilities in the country are lagging way behind in proper disposal of biomedical waste. Read More
Drug Laws & Policy Injections
Health ministry to make it mandatory for physicians to prescribe drugs with generic namesMumbai, Aug 3, 2015: In a bid to further promote the use of generic drugs and also to encourage the rational use of drugs, the Union Health Ministry will soon make it mandatory for all the physicians in the country to prescribe drugs with generic names. Read More
Health Ministry to form NMCN to set up telemedicine infrastructure in all medical colleges Mumbai, Aug 4, 2015: The Union health ministry will soon set up the National Medical College Network (NMCN) as part of its “e-health including telemedicine” programme under which the Ministry will set up telemedicine infrastructure in all medical colleges and institutions to network each other in a phase-wise manner as a greenfield project. The project will be totally supported for five years by the Union health ministry after which the state governments will take over its management. Read More
Maharashtra government forms committee to take action against bogus doctors Mumbai, Aug, 2015: Against the backdrop of the complaints that about 700 bogus doctors are practising in Maharashtra, the State government has formed a committee comprising members from the Maharashtra Medical Council (MMC), Mumbai municipal commissioner and Mumbai police commissioner. The first meeting of the committee was successfully held recently to discuss the actions to be taken against the bogus medical practitioners or quacks. Read More
Pharma Injections
Measures to Contain Deaths from Antibiotic Resistance New Delhi: Based on the information received from the Indian Council of Medical Research (ICMR) and National Centre for Disease Control (NCDC), the Government is not aware about WHO’s report that antibiotic resistance may cause rise in death of Indians to 20 lakhs per year by 2050. Data on deaths due to antibiotic resistance is not being collected at present by the Government. Read More
Scientists find bacteria that prevents type 1 diabetes Washington DC: A set of bacteria known as microbiota, can prevent humans against the development of type 1 diabetes. A pancreatic islet of Langerhans is expressing the immunoregulator antimicrobial peptide CRAM . Read More
Some amazing newly found drug facts:- Omega 3 fatty acid supplementation may improve QOL in cancer patients
Supplementation of omega-3 fatty acids with anti-cancer drugs may improve the treatment response and quality of life (QOL) in cancer patents, according to a study published in the Journal of Parenteral and Enteral Nutrition.
Read More
Global Injections
China sets up world's largest mosquito factory to fight dengue Beijing : China has set up the world's largest mosquito factory in Guangzhou province to tackle dengue fever by releasing one million sterilized mosquitoes every week in a bid to dilute their population. Located in Guangzhou's Science City area, team leader Xi Zhiyong is in charge... Read More
Some serious drug side effects not told to FDA within 15 days Maryland: Companies fail to report roughly one in 10 serious and unexpected medication side effects to the U.S. Food and Drug Administration (FDA) within a 15-day window specified by federal regulations to protect patient safety, a study finds. Read More

Germany links to EU drug traceability platformGermany's medicine traceability system - securPharm - is working under market conditions and is ready to meet the requirements of the Falsified Medicines Directive. That was the message delivered by representatives of the initiative at a conference in Frankfurt to discuss progress with Germany's efforts to comply with the FMD (Directive 2011/62/EU) and make sure patients are protected from counterfeit, expired and recalled drugs.Read More

Drug Dopes
Hetero launches biosimilar Rituximab in India NEW DELHI: Drug firm Hetero has launched biosimilar Rituximab in India used for treatment of certain types of cancers and rheumatoid arthritis under the brand name 'Maball'. Read More
EU bans 700 generic drugs for manipulation of trials by GVK BERLIN: The European Union has banned the marketing of around 700 generic medicines for alleged manipulation of clinical trials conducted by India's pharmaceutical research company GVK Biosciences. The largest EU-wide suspension of sales and distribution of generic drugs ordered by the European Commission will come into effect on August 21 and it will be applicable to all 28 member nations, according to Germany's drug regulator, the Federal Institute for Medicines and Medical Products (BfArM). Read More
Anti-smoking drug from nicotine-eating bacteria Aug 9, 2015: A bacterium that consumes nicotine may help scientists develop a powerful anti-smoking drug, says a study. The researchers found that the bacterial enzyme can be recreated in lab settings and possesses a number of promising characteristics for drug development. Read More
Wockhardt recalls over 50 lakh bottles of various drugs in US NEW DELHI: Wockhardt is recalling over 50 lakh bottles of various drugs, used for treating ailments like high blood pressure and ulcer, in the US market due to deviations in current good manufacturing practice norms laid down by the American health regulator. Read More
US FDA clears first 3-D printed prescription drug WASHINGTON, 4 AUG 2015 : The Food and Drug Administration has approved the first prescription drug made through 3-D printing: a dissolvable tablet that treats seizures. Aprecia Pharmaceuticals said Monday the FDA approved its drug Spritam for adults and children who suffer from certain types of seizures caused by epilepsy. The tablet is manufactured through a layered process via 3-D printing and dissolves when taken with liquid. Read More
USFDA imposes import alert on some Himalaya Drug Company products HYDERABAD: US Food and Drug Administration has imposed an import alert on some of the personal care products manufactured by Himalaya Drug Company at its facilities in Hyderabad, Bengaluru and Himachal Pradesh. Read More
Upcoming Events
UpComing Events
Click Here For More Events
PSM PILL

PSM PSA: Don’t Destroy Your Medical Practice with Fake Drugs

The latest in public service announcements from Partnership for Safe Medicines tells the story of what happens to doctors who make the mistake of purchasing substandard medication. PSM board member Jim Dahl advises physicians ---Don’t Destroy Your Medical Practice with Fake Drugs. Read more of it at : https://www.youtube.com/watch?v=LI5wVQf2m7E
Instead of drawing the attention of authorities, physicians can use PSM’s L.E.A.D.E.R.S. Guide for Physicians at http://www.safemedicines.org/protecting-patients-from-counterfeit-medications-guides-for-doctors.html to protect their patients and their livelihood.

AUSA Jaime Peña shares a tale of Hospital Drug Diversion at Interchange 2014

August 03, 2015: While participating in an Interchange 2014 panel discussion on criminal prosecutions for drug counterfeiting and drug diversion, Jaime Peña, Assistant U.S. Attorney/Senior Litigation Chief, Criminal Division, Colorado District, U.S. Department of Justice, tells a disturbing story of hospital-based drug diversion.

Read More

Frequently Asked Questions Q1. What is Glaucoma?
Answer: Glaucoma is a disease that damages your eye's optic nerve. It usually happens when fluid builds up in the front part of your eye. That extra fluid increases the pressure inside eye, damaging the optic nerve. Glaucoma has been called the "silent thief of sight" because the loss of vision often occurs gradually over a long period of time, and symptoms only occur when the disease is quite advanced. Without proper treatment, glaucoma can lead to blindness. Worldwide, glaucoma is the second-leading cause of blindness after cataracts.
Read More>>>

Q2. What is a cataract?
Answer: A cataract is a clouding of the lens in the eye leading to a decrease in vision. It can affect one or both eyes. Symptoms include faded colours, blurry vision, halos around light, trouble with bright lights, and trouble seeing at night. The lens is a clear part of the eye that helps to focus light, or an image, on the retina. The retina is the light-sensitive tissue at the back of the eye.
In a normal eye, light passes through the transparent lens to the retina. Once it reaches the retina, light is changed into nerve signals that are sent to the brain.
Read More>>>

Laughter Dose
Blog Addicts
Mr. Anand, Pharma Professional tweets: Great Work PSM India. You do put a very positive impact on our minds!!
Dr. Rajashri Mukherjee, Academician blogs I am impressed by the amazing display and preparation of matter in the newsletter. Appreciation to all!
Mr. Raghav Joshi comments: PSM India’s endeavour has provided us richer knowledge. Thanks for bringing up such good editorial!
This Newsletter is brought to you by
© 2011 Partnership for Safe Medicines India
F-9, 2nd floor, Kailash Colony, New Delhi -110048
www.safemedicinesindia.in; www.safemedicines.org; www.ConsumerConexion.org
Disclaimer : Our newsletter endeavors to compile patient safety information from various sources . PSM India may not be held responsible for any article published in The Prescription.